Head to Head Survey: Semperit Ag Hld (OTCMKTS:SEIGY) & TriSalus Life Sciences (NASDAQ:TLSI)

TriSalus Life Sciences (NASDAQ:TLSI) and Semperit Ag Hld (OTCMKTS:SEIGY) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

Profitability

This table compares TriSalus Life Sciences and Semperit Ag Hld’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TriSalus Life Sciences	-98.45%	N/A	-111.88%
Semperit Ag Hld	-0.58%	-0.89%	-0.42%

Risk & Volatility

TriSalus Life Sciences has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500. Comparatively, Semperit Ag Hld has a beta of 0.05, meaning that its share price is 95% less volatile than the S&P 500.

Institutional and Insider Ownership

2.6% of TriSalus Life Sciences shares are owned by institutional investors. 27.5% of TriSalus Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares TriSalus Life Sciences and Semperit Ag Hld”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TriSalus Life Sciences	$29.43 million	8.86	-$30.05 million	($2.02)	-2.58
Semperit Ag Hld	$732.20 million	0.42	$12.44 million	($0.10)	-37.60

Semperit Ag Hld has higher revenue and earnings than TriSalus Life Sciences. Semperit Ag Hld is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and recommmendations for TriSalus Life Sciences and Semperit Ag Hld, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TriSalus Life Sciences	1	1	2	0	2.25
Semperit Ag Hld	0	0	0	0	0.00

TriSalus Life Sciences presently has a consensus price target of $11.00, suggesting a potential upside of 110.73%. Given TriSalus Life Sciences’ stronger consensus rating and higher possible upside, equities analysts plainly believe TriSalus Life Sciences is more favorable than Semperit Ag Hld.

Summary

TriSalus Life Sciences beats Semperit Ag Hld on 9 of the 14 factors compared between the two stocks.

About TriSalus Life Sciences

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

About Semperit Ag Hld

Semperit Aktiengesellschaft Holding develops, produces, and sells rubber products for the medical and industrial sectors worldwide. It operates through two segments: Semperit Industrial Applications and Semperit Engineered Applications. The company provides hydraulic and industrial hoses; conveyor belts; escalator handrails; profiles for windows, doors and facades, cable car rings, and ski foils; and products for railroad superstructures and toolmaking; and precision liquid silicone parts. It offers handrails; engineered solutions; and provides elastomer and sealing profiles for windows, doors, and facades; and elastomer and wear-resistant protective sheeting. It serves agriculture, bulk transportation systems, construction, manufacturing, health care, mining and port facilities, shipping, packing, household, renewable energy and power generation, process, steel, and automotive industries. Semperit Aktiengesellschaft Holding was founded in 1824 and is headquartered in Vienna, Austria.